Targeting IL-4 for the Treatment of Atopic Dermatitis

Por Chiricozzi A, Maurelli M, Peris K, Girolomoni G
Publicado em 2020-09-01

A patient‐centred approach to biological treatment decision making for psoriasis: an expert consensus

Por Strohal, R., Prinz, J. C., Girolomoni, G., Nast, A.
Publicado no J Eur Acad Dermatol Venereol (2015)

Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update

Por Gisondi, P., PIaserico, S., Bordin, C., Alaibac, M., Girolomoni, G., Naldi, L.
Publicado no J Eur Acad Dermatol Venereol (2020)

Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.

Por Pastore, S, Fanales-Belasio, E, Albanesi, C, Chinni, L M, Giannetti, A, Girolomoni, G
Publicado em 1997

Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.

Por Girolomoni, G, Valle, M T, Zacchi, V, Costa, M G, Giannetti, A, Manca, F
Publicado em 1996

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis

Por Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W.H., Prinz, J.C.
Publicado no J Eur Acad Dermatol Venereol (2017)

A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients...

Por Puig, L., van de Kerkhof, P.C.M., Reich, K., Bachelez, H., Barker, J., Girolomoni, G., Paul, C.
Publicado no J Eur Acad Dermatol Venereol (2017)

In vitro infection of human epidermal Langerhans' cells with HIV-1.

Por Ramazzotti, E, Marconi, A, Re, M C, Girolomoni, G, Cenacchi, G, Vignoli, M, Zambruno, G, Furlini, G, La Placa, M, Giannetti, A
Publicado em 1995

The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada

Por de Bruin‐Weller, M., Gadkari, A., Auziere, S., Simpson, E.L., Puig, L., Barbarot, S., Girolomoni, G., Papp, K., Pink, A.E., Saba, G., Werfel, T., Eckert, L.
Publicado no J Eur Acad Dermatol Venereol (2020)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis surve...

Por van de Kerkhof, P.C.M., Reich, K., Kavanaugh, A., Bachelez, H., Barker, J., Girolomoni, G., Langley, R.G., Paul, C.F., Puig, L., Lebwohl, M.G.
Publicado no J Eur Acad Dermatol Venereol (2015)

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

Por Drucker, A.M., Eyerich, K., de Bruin‐Weller, M.S., Thyssen, J.P., Spuls, P.I., Irvine, A.D., Girolomoni, G., Dhar, S., Flohr, C., Murrell, D.F., Paller, A.S., Guttman‐Yassky, E.
Publicado no Br J Dermatol (2018)

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

Por Alexander, H., Paller, A.S., Traidl‐Hoffmann, C., Beck, L.A., De Benedetto, A., Dhar, S., Girolomoni, G., Irvine, A.D., Spuls, P., Su, J., Thyssen, J.P., Vestergaard, C., Werfel, T., Wollenberg, A., Deleuran, M., Flohr, C.
Publicado no Br J Dermatol (2019)